Insider Transactions in Q1 2022 at Vericel Corp (VCEL)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,738
-14.97%
|
$686,258
$41.43 P/Share
|
|
Mar 01
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.17%
|
$280,000
$14.48 P/Share
|
|
Feb 19
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,875
-2.42%
|
$131,750
$34.9 P/Share
|
|
Feb 19
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,937
+5.28%
|
-
|
|
Feb 19
2022
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
869
-20.14%
|
$29,546
$34.9 P/Share
|
|
Feb 19
2022
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+28.86%
|
-
|
|
Feb 19
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,248
-10.86%
|
$42,432
$34.9 P/Share
|
|
Feb 19
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,812
+19.65%
|
-
|
|
Feb 19
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-1.57%
|
$24,820
$34.9 P/Share
|
|
Feb 19
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+3.62%
|
-
|
|
Feb 11
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,251
-2.1%
|
$113,785
$35.26 P/Share
|
|
Feb 11
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.63%
|
-
|
|
Feb 11
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,564
-15.26%
|
$54,740
$35.26 P/Share
|
|
Feb 11
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+25.46%
|
-
|
|
Feb 11
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
775
-1.7%
|
$27,125
$35.26 P/Share
|
|
Feb 11
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+3.44%
|
-
|
|
Feb 06
2022
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-2.03%
|
$100,617
$33.91 P/Share
|
|
Feb 06
2022
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,937
+4.42%
|
-
|
|
Feb 06
2022
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
931
-12.13%
|
$30,723
$33.91 P/Share
|
|
Feb 06
2022
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+19.63%
|
-
|
|
Feb 06
2022
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-0.7%
|
$10,230
$33.91 P/Share
|
|
Feb 06
2022
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+1.44%
|
-
|